Atherogenic lipid profile and high sensitive C-reactive protein in patients with rheumatoid arthritis

Clinical Biochemistry

Volumn 46, Issue 12, 2013, Pages 1007-1012

  Singh, Harsh Vardhan ^a   Shrivastava, Amit Kumar ^b   Raizada, Arun ^c   Singh, Sanjeev Kumar ^d   Pandey, Aparna ^e   Singh, Neelima ^d   Yadav, Devendra ^c   Sharma, Hemant ^a  

^a HINDU RAO HOSPITAL   (India)

^b Sudha Rustagi College of Dental Sciences and Research   (India)

^c Medanta The Medicity ^*  (India)

^d G R MEDICAL COLLEGE   (India)

^e Narsinhbhai Patel Dental College and Hospital   (India)

Author keywords

Atherogenic lipid profile; High sensitive C reactive protein; Inflammation; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SEX; TRIACYLGLYCEROL BLOOD LEVEL;

ATHEROGENIC LIPID PROFILE; HIGH SENSITIVE C-REACTIVE PROTEIN; INFLAMMATION; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; DEMOGRAPHY; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED;

EID: 84880511491     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.03.023     Document Type: Article

References (39)

1. Turesson C., Matteson E.L. Genetics of rheumatoid arthritis. Mayo Clin Proc 2006, 81:94-101.
2. Solomon D.H., Karlson E.W., Rimm E.B., Cannuscio C.C., Mandl L.A., Manson J.E., et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003, 107:1303-1307.
3. Maradit-Kremers H., Nicola P.J., Crowson C.S., Ballman K.V., Gabriel S.E. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005, 52:722-732.
4. Nicola P.J., Crowson C.S., Maradit-Kremers H., Ballman K.V., Roger V.L., Jacobsen S.J., et al. Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 2006, 54:60-67.
5. Wolfe F., Freundlich B., Straus W.L. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 2003, 30:36-40.
6. Maradit-Kremers H., Crowson C.S., Nicola P.J., Ballman K.V., Roger V.L., Jacobsen S.J., et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005, 52:402-411.
7. Goodson N.J., Silman A.J., Pattison D.J., Lunt M., Bunn D., Luben R., et al. Traditional cardiovascular risk factors measured prior to the onset of inflammatory polyarthritis. Rheumatology 2004, 43:731-736.
8. Rojas-Villarraga A., Ortega-Hernandez O.D., Gomez L.F., Pardo A.L., López-Guzmán S., Arango-Ferreira C., et al. Risk factors associated with different stages of atherosclerosis in Colombian patients with rheumatoid arthritis. Semin Arthritis Rheum 2008, 38:71-82.
9. Boers M., Nurmohamed M.T., Doelman C.J., Lard L.R., Verhoeven A.C., Voskuyl A.E., et al. Influence of glucocorticoid and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis 2003, 62:842-845.
10. Kowsalya R., Sreekantha, Vinod C., Remya Dyslipidemia with altered oxidant-antioxidant status in rheumatoid arthritis. International Journal of Pharma and Bio Sciences 2011, 2:424-428.
11. Park Y.B., Lee S.K., Lee W.K., Suh C.H., Lee C.W., Lee C.H., et al. Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol 1999, 26:1701-1704.
12. Shrivastava A.K., Pandey A. Inflammation and rheumatoid arthritis. J Physiol Biochem October 2012, 10.1007/s13105-012-0216-5.
13. Molenaar E.T., Voskuyl A.E., Familian A., van Mierlo G.J., Dijkmans B.A., Hack C.E. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein. Arthritis Rheum 2001, 44:997-1002.
14. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
15. Park Y.B., Choi H.K., Kim M.Y., Lee W.K., Song J., Kim D.K., et al. Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med 2002, 113:188-193.
16. Skoumas J., Pitsavos C., Panagiotakos D.B., Chrysohoou C., Zeimbekis A., Papaioannou I., et al. Physical activity, high density lipoprotein cholesterol and other lipids levels, in men and women from the ATTICA study. Lipids Health Dis 2003, 2:3.
17. Aviña-Zubieta J.A., Choi H.K., Sadatsafavi M., Etminan M., Esdaile J.M., Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008, 59:1690-1697.
18. Warrington K.J., Kent P.D., Frye R.L., Lymp J.F., Kopecky S.L., Goronzy J.J., et al. Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther 2005, 7:R984-R991.
19. Douglas K.M., Pace A.V., Treharne G.J., Saratzis A., Nightingale P., Erb N., et al. Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann Rheum Dis 2006, 65:348-353.
20. Barsky A.J., Peekna H.M., Borus J.F. Somatic symptom reporting in women and men. J Gen Intern Med 2001, 16:266-275.
21. Sokka T., Toloza S., Cutolo M., Kautiainen H., Makinen H., Gogus F., et al. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study. Arthritis Res Ther 2009, 11:R7.
22. Cutolo M., Seriolo B., Villaggio B., Pizzorni C., Craviotto C., Sulli A. Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Ann N Y Acad Sci 2002, 966:131-142.
23. Borman P., Seçkin U., Yücel M. Dyslipidemia in patients with rheumatoid arthritis and osteoarthritis. Physical Medicine 1999, 2:5-9.
24. van Halm V.P., Nielen M.M., Nurmohamed M.T., van Schaardenburg D., Reesink H.W., Voskuyl A.E., et al. Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis 2007, 66:184-188.
25. Carpentier Y.A., Scruel O. Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Curr Opin Clin Nutr Metab Care 2002, 5:153-158.
26. Esteve E., Ricart W., Fernández-Real J.M. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 2005, 24:16-31.
27. Situnayake R.D., Kitas G. Dyslipidaemia and rheumatoid arthritis. Ann Rheum Dis 1997, 56:341-342.
28. Tall A.R. Plasma cholesteryl ester transfer protein. J Lipid Res 1993, 34:1255-1274.
29. Toms T.E., Panoulas V.F., Kitas G.D. Dyslipidaemia in rheumatological autoimmune diseases. Open Cardiovasc Med J 2011, 5:64-75.
30. Hurt-Camejo E., Paredes S., Masana L., Camejo G., Sartipy P., Rosengren B., et al. Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile. Arthritis Rheum 2001, 44:2761-2767.
31. Kotler D.P. Cachexia. Ann Intern Med 2000, 133:622-634.
32. Dessein P.H., Joffe B.I., Singh S. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 2005, 7:R634-R643.
33. Pasceri V., Yeh E.T. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 1999, 100:2124-2126.
34. Choi H.K., Seeger J.D. Lipid profiles among US elderly with untreated rheumatoid arthritis - the Third National Health and Nutrition Examination Survey. J Rheumatol 2005, 32:2311-2316.
35. Jonsson S.W., Backman C., Johnson O., Karp K., Lundström E., Sundqvist K.G., et al. Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 2001, 28:2597-2602.
36. Gonzalez M.A., Selwyn A.P. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med 2003, 115:99S-106S.
37. Goodson N.J., Symmons D.P., Scott D.G., Bunn D., Lunt M., Silman A.J. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year follow-up study of a primary care-based inception cohort. Arthritis Rheum 2005, 52:2293-2299.
38. Masi A.T., Aldag J.C., Sipes J. Do elevated levels of serum C-reactive protein predict rheumatoid arthritis in men: correlations with pre-RA status and baseline positive rheumatoid factors. J Rheumatol 2001, 28:2359-2361.
39. White D., Fayez S., Doube A. Atherogenic lipid profiles in rheumatoid arthritis. N Z Med J 2006, 119:U2125.